BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1485281)

  • 1. [Internal medicine therapy of venous thromboembolism].
    Tsakiris DA; Marbet GA
    Ther Umsch; 1992 Dec; 49(12):833-6. PubMed ID: 1485281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of deep vein thrombosis and pulmonary embolism.
    Turkstra F; Koopman MM; Büller HR
    Thromb Haemost; 1997 Jul; 78(1):489-96. PubMed ID: 9198202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Low molecular weight heparin in venous thromboembolism. Mechanism of action, therapy and prophylaxis].
    Stammler F; Diehm C
    Dtsch Med Wochenschr; 1998 May; 123(19):604-11. PubMed ID: 9618643
    [No Abstract]   [Full Text] [Related]  

  • 4. Low molecular weight heparins (LMWH) in the treatment of patients with acute venous thromboembolism.
    Hirsh J; Siragusa S; Cosmi B; Ginsberg JS
    Thromb Haemost; 1995 Jul; 74(1):360-3. PubMed ID: 8578485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic indications for acute venous thromboembolism. Current status and future perspectives].
    Prandoni P; Simioni P; Pagnan A
    Minerva Cardioangiol; 2003 Aug; 51(4):361-71. PubMed ID: 12900718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DVT and pulmonary embolism: Part II. Treatment and prevention.
    Ramzi DW; Leeper KV
    Am Fam Physician; 2004 Jun; 69(12):2841-8. PubMed ID: 15222649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Strategies for utilization of anticoagulants in pulmonary embolism].
    Fartoukh M; Simonneau G
    Rev Mal Respir; 1999 Nov; 16(5 Pt 2):949-60. PubMed ID: 10907444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of venous thromboembolism.
    ten Cate JW; Koopman MM; Prins MH; Büller HR
    Thromb Haemost; 1995 Jul; 74(1):197-203. PubMed ID: 8578457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of venous thromboembolism].
    Niederer A; Wuillemin WA
    Praxis (Bern 1994); 2001 Feb; 90(6):213-9. PubMed ID: 11235642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of venous thromboembolism.
    Ginsberg JS
    N Engl J Med; 1996 Dec; 335(24):1816-28. PubMed ID: 8943165
    [No Abstract]   [Full Text] [Related]  

  • 12. Subcutaneous low-molecular-weight heparin fragmin versus intravenous unfractionated heparin in the treatment of acute non massive pulmonary embolism: an open randomized pilot study.
    Meyer G; Brenot F; Pacouret G; Simonneau G; Gillet Juvin K; Charbonnier B; Sors H
    Thromb Haemost; 1995 Dec; 74(6):1432-5. PubMed ID: 8772215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug therapy of deep venous thrombosis].
    Bounameaux H
    Ther Umsch; 1996 Apr; 53(4):272-6. PubMed ID: 8658349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.
    Hull RD; Pineo GF; Stein P
    Int Angiol; 1998 Dec; 17(4):213-24. PubMed ID: 10204652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients.
    Prandoni P; Villalta S; Bagatella P; Rossi L; Marchiori A; Piccioli A; Bernardi E; Girolami B; Simioni P; Girolami A
    Haematologica; 1997; 82(4):423-8. PubMed ID: 9299855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of unfractionated heparin and low molecular weight heparin in pulmonary thromboembolism: meta-analysis].
    Zhai ZG; Wang C; Liu YM; Qin ZQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):221-6. PubMed ID: 15266820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis.
    Couturaud F; Julian JA; Kearon C
    Thromb Haemost; 2001 Oct; 86(4):980-4. PubMed ID: 11686355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusual onset of venous thromboembolism and heparin-induced thrombocytopenia in a patient with essential thrombocythemia.
    Lapecorella M; Lucchesi A; Di Ianni M; Napolitano M; Coletti G; Di Leonardo G; Dell'Orso L; Barnabei R; Mariani G
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):85-90. PubMed ID: 19923984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of recurrence of thromboembolic disease: maintenance of anticoagulant therapy].
    Enrico JF
    Ther Umsch; 1989 Oct; 46(10):732-8. PubMed ID: 2814910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [-Anticoagulant drugs-].
    Gulba DC
    Herz; 1996 Feb; 21(1):12-27. PubMed ID: 8647576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.